Experimental atherosclerosis in rabbits;Aterosclerose experimental em coelhos

Arquivos Brasileiros de Cardiologia

Volumn 95, Issue 2, 2010, Pages 272-278

  Dornas, Waleska C ^a   De Oliveira, Tânia T ^b   Augusto, Luis E Franklin ^b   Nagem, Tanus J ^a  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

Author keywords

Atherosclerosis; Cholesterol; Hypercholesterolemia; Rabbits

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; NITRIC OXIDE; NITRITE; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL METABOLISM; ENDOTHELIAL DYSFUNCTION; HYPERCHOLESTEROLEMIA; METABOLIC REGULATION; NONHUMAN; RABBIT; REVIEW; THROMBOSIS; TRANSGENIC ANIMAL;

ANIMALS; ATHEROSCLEROSIS; CHOLESTEROL; CHOLESTEROL, DIETARY; CORONARY VESSELS; DIET; DIET, ATHEROGENIC; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HYPERCHOLESTEROLEMIA; RABBITS;

EID: 77957315685     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2010001200020     Document Type: Review

References (63)

1. Sociedade Brasileira de Cardiologia. Sociedade Brasileira de Endocrinologia. II Consenso Brasileiro sobre dislipidemias. Detecçã o, avaliação e tratamento. Arq Bras Endocrinol Metab. 1999; 43: 287-305.
2. Moghadasian MH. Experimental atherosclerosis: a historical overview. Life Sci. 2002; 70 (8): 855-65.
3. Kritchevsky D. Dietary protein, cholesterol and atherosclerosis: a review of the early history. J Nutr. 1995; 125 (3): 587S-593S.
4. Lichtman AH, Clinton SK, Iyama K, Connelly PW, Libby P, Cybulsky MI. Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate. Arterioscler Thromb Vasc Biol. 1999; 19 (8): 1938-44.
5. Percegoni N, Oliveira TT, Nagem TJ, Lima LRP, Lima EQ, Matta SLP. Efeito de caseína, proteína isolada de soja e colestiramina em coelhos hiperlipidêmicos. Rev Cienc Farm. 2004; 25: 99-110.
6. Oliveira TT, Nagem TJ, Pinto AS, Lopes RM, Camini NA, Leão MA, et al. Ação de chitosan e naringenina em coelhos hiperlipidê micos. Rev Portuguesa de Farmácia. 2001; 1: 43-8.
7. Lima LRP, Oliveira TT, Nagem TJ, Pinto AS, Stringheta PC, Tinoco ALA, et al. Bixina, norbixina e quercetina e seus efeitos no metabolismo lipídico de coelhos. Braz J Vet Res Anim Sci. 2001; 38 (4): 196-200.
8. Lima LRP, Oliveira TT, Nagem TJ, Pinto AX, Tinoco ALA, Silva JF, et al. Ação terapêutica e inocuidade no metabolismo de quercetina, bixina e norbixina em coelhos hiperlipidêmicos. Tecnol Cien Agropec. 2008; 2 (1): 51-6.
9. Lima LRP, Oliveira TT, Nagem TJ, Pinto AS, Oliveira MGA, Tinoco ALA, et al. Rutina e bixina do urucum e suas ações hipolipidêmicas em coelhos. Rev Bras Farm. 2000; 81 (3): 58-62.
10. Lima LRP, Oliveira TT, Nagem TJ. Efeitos do flavonóide quercetina e dos corantes bixina e norbixina sobre parâmetros sanguíneos de coelhos. Rev Nutr. 2003; 16 (3): 305-14.
11. Lima LRP, Oliveira TT, Nagem TJ, Pinto AS, Oliveira MGA, Tinoco ALA, et al. Controle de hiperlipidemia em coelhos tratados com flavonóides e corantes naturais do urucum. Rev Acta Farmacêutica Boanarense (Buenos Aires). 2001; 20 (1): 53-7.
12. Virtuoso LS, Oliveira TT, Nagem TJ, Pinto AS, Tinoco ALA. Efeitos de rutina, colestiramina e betalaína no controle de lipídeos em soros de coelhos hiperlipidêmicos. Rev Bras Anal Clin. 2001; 33 (2): 85-9.
13. Iturry-Yamamoto G, Alves AA, Picon PD. Propriedades anti- aterogênicas do fator relaxante derivado do endotélio (óxido nítrico). Arq Bras Cardiol. 1997; 69 (5): 349-57.
14. Sun YP, Lu NC, Parmley WW, Hollenbeck CB. Effects of cholesterol diets on vascular function and atherogenesis in rabbits. Exp Biol Med. 2000; 224 (3): 166-71.
15. Laight DW, Matz J, Caesar B, Carrier MJ, Anggard EE. Investigation of endogenous nitric oxide vascular function in the carotid artery of cholesterol-fed rabbits. Br J Pharmacol. 1996; 117 (7): 1471-4. (Pubitemid 26116772)
16. Kawashima S, Yokoyama M. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol. 2004; 24 (6): 998-1005.
17. Jiménez A, Arriero MM, López-Blava A, González- Fernandez F, Garcia R, Fortes J, et al. Regulation of endothelial nitric oxide synthase expression in the vascular wall and in mononuclear cells from hypercholesterolemic rabbits. Circulation. 2001; 104 (15): 1822-30.
18. Vasquez-Vivar J, Duquaine D, Whitsett J, Kalyanaraman B, Rajagopalan S. Altered tetrahydrobiopterin metabolism in atherosclerosis: implications for use of oxidized tetrahydrobiopterin analogues and thiol antioxidants. Arterioscler Thromb Vasc Biol. 2002; 22 (10): 1655-61.
19. Harrison DG, Ohara Y. Physiologic consequences of increased vascular oxidant stresses in hypercholesterolemia and atherosclerosis: implications for impaired vasomotion. Am J Cardiol. 1995; 75 (6): 75B-81B.
20. Matz J, Andersson TLG, Ferns GAA, Änggard EE. Dietary vitamin E increases the resistance to lipoprotein oxidation and attenuates endothelial dysfunction in the cholesterol-fed rabbit. Atherosclerosis. 1994; 110 (2): 241-9.
21. Verbeuren TJ, Bonhomme E, Lbie M, Simonet S. Evidence for induction of a non-endothelial NO synthase in aortas of cholesterol-fed rabbits. J Cardiovasc Pharmacol. 1993; 21 (5): 841-5.
22. Pomerantz KB, Hajjar DP, Levi L, Gross SS. Cholesterol enrichment of arterial smooth muscle cells upregulates cytokine-induced nitric oxide synthesis. Biochem Biophys Res Commun. 1993; 191 (1): 103-9.
23. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci USA. 1992; 89 (23): 11259-63.
24. Holm P, Andersen HL, Arroe G, Stender S. Gender gap in aortic cholesterol accumulation in cholesterol-clamped rabbits: role of the endothelium and mononuclear-endothelial cell interaction. Circulation. 1998; 98 (24): 2731-7. (Pubitemid 28564009)
25. Nathan L, Pervin S, Singh R, Rosenfeld M, Chaudhuri G. Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo: possible mechanisms for gender differences in atherosclerosis. Circ Res. 1999; 85 (4): 377-85.
26. Nematbakhsh M, Haghjooyjanmard S, Mahmoodi F, Monajemi AR. The prevention of endothelial dysfunction through endothelial cell apoptosis inhibition in a hypercholesterolemic rabbit model: the effect of L-arginine supplementation. Lipids Health Dis. 2008; 7: 27.
27. Knopfholz J, Précoma DB, Brofman PRS, Bier GE, da Silva RFKC, Silva APK, et al. Efeito da L-arginina na neoproliferação intimal e no remodelamento arterial após lesão por balão, em ilíacas de coelhos hipercolesterolêmicos. Arq Bras Cardiol. 2006; 87: 520-4.
28. Haghjooyjavanmard S, Nematbakhsh M, Monajemi A, Soleimani M. Von Willebrand factor, C-reactive protein, nitric oxide, and vascular endothelial growth factor in a dietary reversal model of hypercholesterolemia in rabbit. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008; 152 (1): 91-5.
29. Sun H, Koike T, Ichikawa T, Hatakeyama K, Shiomi M, Zhang B, et al. C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance. Am J Pathol. 2005; 167 (4): 1139-48.
30. Hernández LR, Lundberg U, Arocha-Piñango CL. Experimental thrombosis I: relation with fibrinogen and other haemostatic parameters. Thromb Res. 2000; 99 (3): 295-305.
31. Minor RL, Myers PR, Guerra R Jr, Bater JN, Harrison DG. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest. 1990; 86 (6): 2109-16.
32. Kolodgie FD, Katocs AS Jr, Largis EE, Wrenn SM, Cornhill JF, Herderick EE, et al. Hypercholesterolemia in the rabbit induced by feeding graded amounts of low-level cholesterol: methodological considerations regarding individual variability in response to dietary cholesterol and development of lesion type. Arterioscler Thromb Vasc Biol. 1996; 16 (12): 1454-64.
33. Spagnoli LG, Orlandi A, Mauriello A, Santeusanio G, de Angelis C, Lucreziotti R, et al. Aging and atherosclerosis in the rabbit. 1. Distribution, prevalence and morphology of atherosclerotic lesions. Atherosclerosis. 1991; 89 (1): 11-24.
34. Holvoet P, Collen D. Beta-VLDL hypercholesterolemia relative to LDL hypercholesterolemia is associated with higher levels of oxidized lipoproteins and a more rapid progression of coronary atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol. 1997; 17 (11): 2376-82.
35. Crowther MA. Pathogenesis of atherosclerosis. Hematology. 2005: 436-41.
36. Rosenfeld ME, Tsukada T, Gown AM, Ross R. Fatty streak initiation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis. 1987; 7 (1): 9-23. (Pubitemid 17014538)
37. Johnstone MT, Botnar RM, Perez AS, Stewart R, Quist WC, Hamilton JA, et al. In vivo magnetic resonance imaging of experimental thrombosis in a rabbit model. Arterioscler Thromb Vasc Biol. 2001; 21 (9): 1556-60.
38. Kamimura R, Suzuki S, Sakamoto H, Miura N, Misumi K, Miyahara K. Development of atherosclerotic lesions in cholesterol-loaded rabbits. Exp Anim. 1999; 48 (1): 1-7. (Pubitemid 129565740)
39. Staprans I, Pan X-M, Rapp JH, Feingold KR. Oxidized cholesterol in the diet accelerates the development of aortic atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol. 1998; 18 (6): 977-83.
40. Nakazato K, Ishibashi T, Shindo J, Shiomi M, Maruyama Y. Expression of very low density lipoprotein receptor mRNA in rabbit atherosclerotic lesions. Am J Pathol. 1996; 149 (6): 1831-8.
41. Helft G, Worthley SG, Fuster V, Fayad ZA, Zaman AG, Corti R, et al. Progression and regression of atherosclerotic lesions: monitoring with serial noninvasive magnetic resonance imaging. Circulation. 2002; 105 (8): 993-8. (Pubitemid 34184580)
42. Kitajima S, Sakuma S, Morimoto M. Macroscopic distribution of coronary atherosclerotic lesions in cholesterol-fed rabbits. Exp Anim. 1998; 47 (4): 221-7.
43. Lee RT, Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol. 1997; 17 (10): 1859-67.
44. Shiomi M, Ito T, Yamada S, Kawashima S, Fan J. Correlation of vulnerable coronary plaques to sudden cardiac events: lessons from a myocardial infarction-prone animal model (the WHHLMI rabbit). J Atheroscler Thromb. 2004; 11 (4): 184-9.
45. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995; 91 (11): 2844-50.
46. Rekhter MD, Hicks GW, Brammer DW, Work CW, Kim JS, Gordon D, et al. Animal model that mimics atherosclerotic plaque rupture. Circ Res. 1998; 83 (7): 705-13.
47. Uint L, Laurindo FR, Lopes EA, Da-Luz PL. Ballon-induced endothelial denudation promotes deep injury of the arterial wall. Braz J Med Biol Res. 1989; 22 (7): 913-5.
48. Cullen P, Baetta R, Bellosta S, Bernini F, Chinetti G, Cignarella A, et al. MAFAPS Consortium. Rupture of the atherosclerotic plaque: does a good animal model exist? Arterioscler Thromb Vasc Biol. 2003; 23 (4): 535-42.
49. Rekhter MD, Hicks GW, Brammer DW, Hallak H, Kindt E, Chen J, et al. Hypercholesterolemia causes mechanical weakening of rabbit atheroma. Circ Res. 2000; 86 (1): 101-8.
50. Broeders MA, Tangelder GJ, Slaaf DW, Reneman RS, Oude Egbrink MG. Hypercholesterolemia enhances thromboembolism in arterioles but not venules: complete reversal by L-arginine. Arterioscler Thromb Vasc Biol. 2002; 22 (4): 680-5.
51. Aikawa M, Rabkin E, Okada Y, Voglic SJ, Clinton SK, Brinckerhoff CE, et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation. 1998; 97 (24): 2433-44. (Pubitemid 28278188)
52. Corseaux D, Meuride T, Six I, Rugeri L, Ezekowitz MD, Rouvier P, et al. Basic fibroblast growth factor increases tissue factor expression in circulating monocytes and in vascular wall. Circulation. 2000; 101 (16): 2000-6.
53. Abela GS, Picon PD, Friedl SE, Gebara OC, Miyamoto A, Federman M, et al. Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model. Circulation. 1995; 91 (3): 776-84.
54. Moghadasian MH, Frohlich JJ, McManus BM. Advances in experimental dyslipidemia and atherosclerosis. Lab Invest. 2001; 81 (9): 1173-83.
55. Chapman MJ. Animal lipoproteins: chemistry, structure, and comparative aspects. J Lipid Res. 1980; 21: 789-853.
56. Greeve J, Altkemper I, Dieterich J-H, Greten H, Windler E. Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing lipoproteins. J Lipid Res. 1993; 34: 1367-83. (Pubitemid 23230314)
57. Nagashima M, McLean JW, Lawn RL. Cloning and mRNA tissue distribution of rabbit cholesteryl ester transfer protein. J Lipid Res. 1988; 29: 1643-9.
58. Xu G, Salen G, Shefer S, Ness GC, Nguyen LB, Parker TS, et al. Unexpected inhibition of cholesterol 7 alpha-hydroxylase by cholesterol in New Zealand white and Watanabe heritable hyperlipidemic rabbits. J Clin Invest. 1995; 95 (4): 1497-504.
59. Overturf ML, Smith SA, Hewett-Emmett D, Loose-Mitchell DS, Soma MR, Gotto AM Jr, et al. Development and partial metabolic characterization of a dietary cholesterol-resistant colony of rabbits. J Lipid Res. 1989; 30 (2): 263-73.
60. Xu G, Shneider BL, Shefer S, Nguyen LB, Batta AK, Tint GS, et al. Ileal bile acid transport regulates bile acid pool, synthesis, and plasma cholesterol levels differently in cholesterol-fed rats and rabbits. J Lipid Res. 2000; 41 (2): 298-304.
61. Poorman JA, Buck RA, Smith SA, Overturf ML, Loose-Mitchell DS. Bile acid excretion and cholesterol 7□-hydroxylase expression in hypercholesterolemia- resistant rabbits. J Lipid Res. 1993; 34 (10): 1675-85.
62. Aldini R, Ussia G, Roda A, Cilioni CG, Rizzoli R, Calcaterra D, et al. Evaluation of the ileal absorption capacity for bile acids in the rabbit. Eur Surg Res. 1990; 22 (2): 93-100.
63. Higaki J, Hara S, Takasu N, Tonda K, Miyata K, Shike T, et al. Inhibition of ileal Na+/bile acid cotransporter by S-8921 reduces serum cholesterol and prevents atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol. 1998; 18 (8): 1304-11. (Pubitemid 28376188)